South Africa’s Biovac Institute will start local production of Sanofi’s Hexaxim vaccine next year and Pfizer’s anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.
Eleven pharma companies led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing sector since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines.
US drugmaker Pfizer Inc said that early data has helped it identify a drug candidate with the potential to help treat patients infected with the novel coronavirus.
Developing countries need to urgently audit their cold storage, transport capabilities and infrastructure, to prepare for storing and distributing the vaccines to their people. When COVID-19 hit the world smack in the face in the first quarter of 2020,
So we have a vaccine. Maybe. Though let’s be honest, nothing has actually changed. Yet. While the news has been greeted by many as a sign of an imminent return to normal (especially in the stock market), the vaccine is still several months
Finally, there seems to be some light at the end of what looks like a long, long tunnel. After being pummelled by the ravages of the much hated and feared coronavirus for months, which has killed over a million people,
The US Food and Drug Administration has not said how long it will take to study the vaccine data, but the government expects to give the green light for the vaccine in the first two weeks of December.